Appian provides low-code automation platform that accelerates the creation of business applications, enabling its customers to automate their business. The company's platform automates the creation of forms, data flows, records, reports and other software elements that would otherwise need to be manually coded. The company'snSelf-Assembling Interface Layer technology ensures that applications developed on its platform can be deployed across a range of mobile and desktop devices, including desktop web browsers, tablets and mobile phones. The company's platform can be deployed in the cloud or on-premises, with organizations able to access the same functionality and data sources in various cases.

Clear Channel Outdoor Holdings is a holding company. Through its subsidiaries, the company is an outdoor advertising company providing clients with advertising activities through billboards, street furniture displays, transit displays and other out-of-home advertising displays. The company's segments include:, Americas outdoor advertising, which consists of printed and digital billboards, transit displays, including airports, street furniture and wallscapes and other spectaculars; and International outdoor advertising, which includes its operations in Europe, Asia and Latin America and consists of street furniture, billboards, transit displays, retail displays, public bike programs and other spectaculars.

Comtech Telecommunications is a provider of communications solutions for both commercial and government customers. The company's reportable operating segments include: Commercial Solutions, which provides satellite ground station technologies (such as modems and amplifiers) and public safety and location technologies (such as 911 call routing and mapping solutions); and Government Solutions, which provides technologies (such as tactical satellite-based networks and ongoing support for communication networks) and transmission technologies (such as troposcatter systems and solid-state amplifiers) to government end-users, international customers and domestic prime contractors.

Culp operates three segments: mattress fabrics, which markets primarily knitted and woven fabrics, as well as sewn covers made from those fabrics, which are used in the production of bedding products; upholstery fabrics, which markets a variety of fabric products that are used principally in the production of residential and commercial upholstered furniture, as well as window treatment products and installation services for customers in the hospitality and commercial industries; and home accessories, which markets a variety of bedding accessories and home goods directly to consumers and businesses through global e-commerce and business-to-business sales channels.

CVD Equipment designs, develops and manufactures a range of chemical vapor deposition, gas control and other equipment and process solutions used to develop and manufacture materials and coatings for research and industrial applications. The company operates through three segments: CVD/First Nano, which supplies chemical vapor deposition systems; SDC, which designs and manufactures ultra-high purity gas and chemical delivery control systems; and CVD Materials, which has several elements and product groups including the Tantaline corrosion resistant surface treatment, the MesoScribe direct write, the Electronic Materials for electronics and Carbon Composite products.

Dave & Buster's Entertainment is an owner and operator of entertainment and dining venues (stores) that operate under the name Dave & Buster's. The company's concept is to provide its customers the opportunity to Eat Drink Play and Watch all in one location for adults and families, while serving food and beverages. The company's Eat and Drink is provided through a menu of entrees and appetizers and a selection of non-alcoholic and alcoholic beverages. The company's Play and Watch offerings provide an assortment of entertainment attractions centered around playing games and watching live sports and other televised events.

EOG Resources, together with its subsidiaries, explores for, develops, produces and markets crude oil, natural gas liquids and natural gas primarily in main producing basins in the United States, The Republic of Trinidad and Tobago, The People's Republic of China, Canada and, from time to time, select other international areas.

Everspin Technologies is a provider of magnetoresistive random access memory (MRAM) solutions. The company's portfolio of MRAM technologies, including Toggle MRAM and Spin-transfer Torque MRAM (STT-MRAM), is delivering persistence non-volatile memories that transform how mission-critical data is protected against power loss. The company's MRAM solutions allow its customers in the industrial, automotive and transportation, and enterprise storage markets to design systems without the need for batteries or capacitors. The company's MRAM solutions as well as other offerings include: Toggle MRAM; Spin-Transfer Torque MRAM; and Tunnel Magneto Resistance Sensors.

G1 Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company's product pipeline includes three clinical candidates: trilaciclib, a short-acting intravenous cyclin-dependent kinases (CDK) 4/6 inhibitor that preserves hematopoietic stem and progenitor cells and immune system function; lerociclib, an oral CDK4/6 inhibitor that inhibits tumor proliferation and growth; and G1T48, an oral selective estrogen receptor degrader that inhibits estrogen receptor driven tumor proliferation.

Heska sells veterinary and animal health diagnostic and specialty products. The company's segments are: Core Companion Animal, which includes, primarily for canine and feline use, Point of Care laboratory instruments and consumables, digital imaging diagnostic instruments, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings such as in-clinic diagnostic tests and heartworm preventive products; and Other Vaccines and Pharmaceuticals, which includes private label vaccine and pharmaceutical production, primarily for cattle but also for other species including equine, porcine, avian, feline and canine.

JELD-WEN Holding is a holding company. Through its subsidiaries, the company is a door and window manufacturer. The company designs, produces, and distributes a range of interior and exterior doors, wood, vinyl, and aluminum windows, and related products for use in the construction and repair and remodel of residential homes and, to a lesser extent, non-residential buildings. The company markets its products under the JELD-WEN brand, along with several brands such as Swedoor and DANA in Europe and Corinthian, Stegbar, and Trend in Australia. The company's customers include wholesale distributors and retailers as well as individual contractors and consumers. The company has three segments: North America, Europe, and Australasia.

Jounce Therapeutics is a clinical stage immunotherapy company dedicated to transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors. The company's product candidates include: vopratelimab, which is a clinical stage monoclonal antibody that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of certain T cells commonly found in various solid tumors; JTX-4014, which is a clinical-stage anti-PD-1 antibody that the company is developing primarily for use in combination with future product candidates; and JTX-8064, which is an antibody that binds to LILRB2, a cell surface receptor expressed on macrophages.

Lovesac is a technology omni-channel company that designs, manufactures and sells furniture comprised of couches called Sactionals and foam beanbag chairs called Sacs. The company markets and sells its products through showrooms and online sales.

Myomo is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The company develops and markets the MyoPro product line. MyoPro is a myoelectric-controlled upper limb brace, or orthosis. The orthosis is a rigid brace used for the purpose of supporting a patient's weak or deformed arm to enable and improve functional activities of daily living, ADLs, in the home and community. The company's devices are referred for patients at rehabilitation facilities, including, among others, the Mayo Clinic, Cleveland Clinic, Walter Reed National Military Medical Center, and VA hospitals across the country.

NGM Biopharmaceuticals is a biopharmaceutical company. The company is focused on the following programs: Aldafermin, which is for the treatment of non-alcoholic steatohepatitis (NASH); NGM313 (MK-3655), which is for the treatment of NASH and type 2 diabetes; NGM120, which is designed to block the effects of elevated growth differentiation factor 15 levels on cancer anorexia/cachexia syndrome, and, possibly, tumors; NGM217, which is designed to restore pancreatic islet function and increase insulin production in patients with diabetes; NGM621, which is designed to decrease levels of this protein implicated in the dry form of AMD; and NGM395, which is for the treatment of metabolic syndrome.

OptiNose is pharmaceutical company focused on the development and commercialization of products for patients treated by ear, nose and throat and allergy specialists. The company's first commercial product, XHANCE? (fluticasone propionate) nasal spray, 93 mcg, is a therapeutic utilizing its key Optinose Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps and, if approved, chronic rhinosinusitis without nasal polyps (chronic sinusitis). The company's other candidate includes OPN-300, which combines an Optinose EDS with oxytocin to target two orphan indications: Prader-Willi syndrome and autism spectrum disorder.

Scholar Rock is a biopharmaceutical company. The company's primary product candidate, SRK-015, is a selective, fully human, monoclonal antibody, with a mechanism of action that results in inhibition of the activation of the growth factor, myostatin, in skeletal muscle. The company's second product candidate is SRK-181 and is being developed for the treatment of cancers resistant to checkpoint blockade therapies, such as anti-PD1 antibodies. The company's third antibody program targets the signaling of bone morphogenetic protein 6, another member of the TGF? superfamily, which is involved in a set of biological processes in various parts of the body.

SeaChange International is engaged in the delivery of multiscreen, advertising and over the top video management solutions. The company's software products and services facilitate the aggregation, licensing, management and distribution of video and advertising content for service providers, telecommunications companies, satellite operators and broadcasters. The company sells its software products and services to service providers including: operators, telecommunications companies, satellite operators, and broadcasters. The company's business is focused on these product areas: video platform, content management, advertising and user experience. The company provides other services, maintenance and support for its products.

Travelzoo provides insider deals on travel, entertainment, and lifestyle experiences across multiple digital platforms, including email, web, social media and mobile applications. The company's publications and products include the Travelzoo website (travelzoo.com), the Travelzoo iPhone and Android apps, the Travelzoo Top 20? email newsletter, and the Newsflash email alert service. The company operates the Travelzoo Network, a network of third-party websites that list deals published by Travelzoo. The Travelzoo website includes Local Deals and Getaway listings that allow its members to purchase vouchers for deals from local businesses such as spas, hotels and restaurants.

Veeva Systems provides industry cloud solutions for the life sciences industry. Veeva Commercial Cloud is a suite of multichannel customer relationship management applications, a commercial data warehouse, territory allocation and alignment applications, master data management applications and customer reference and data and services. Veeva Vault is the company's suite of cloud-based, enterprise content management applications that address the content management requirements for the company's customers'commercial functions, including medical and sales and marketing, and key research and development functions, including clinical, regulatory, quality, and, when available, safety.

Wayfair is a holding company. Through its e-commerce business model, the company provides customers with browsing, merchandising and product discovery for products from various suppliers. The company has online selections of furniture, decor, decorative accents, housewares, seasonal decor and other home goods. The company's mobile app also provides customers a way to shop for their home from their home using its View in Room 3D augmented reality tool. The company's sites include: Wayfair, Joss & Main, AllModern, Birch Lane, and Perigold. Wayfair is the only one of the company's sites that also operates internationally, operating as Wayfair.ca in Canada, Wayfair.co.uk in the U.K. and Wayfair.de in Germany.

XOMA is a biotech royalty aggregator with a portfolio of pre-commercial therapeutic candidates. The company's monoclonal antibodies and technologies product candidates are: IL-2, which targets Interleukin 2 as a therapy for metastatic melanoma and renal cell carcinoma; PTH1R, an anti-parathyroid receptor pipeline that includes several functional antibody antagonists targeting PTH1R, a G-protein-coupled receptor involved in the regulation of calcium metabolism; XMetA, an insulin receptor-activating antibody designed to provide long-acting reduction of hyperglycemia in Type 2 diabetic patients; X213, an allosteric inhibitor of prolactin action.